7 unknown, 5 completed, 2 not yet recruiting, 1 active not recruiting. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Unknown 7, Completed 5, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1 |
Follow Myositis: new trials by email Literature Review of Myositis trials Research Report on Myositis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies maraviroc (Selzentry, Celsentri) - Myositis | Phase 4 | Not yet recruiting | Chinese University of Hong Kong | 10 | 2026-09-01 | 2026-06-30 |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| 3T Therapy in the Treatment of MDA5-positive Dermatomyositis Tofacitinib 5 MG - Dermatomyositis | Phase 4 | Enrolling by invitation | Second Affiliated Hospital, Zhejiang University, School of Medicine | 133 | 2024-03-19 | 2024-06-03 |
| Myositis Interstitial Lung Disease Nintedanib Trial Nintedanib, Placebo, Standard of Care - Myositis Associated Interstitial Lund Disease (MA-ILD) | Phase 4 | Completed | Rohit Aggarwal, MD | 62 | 2023-08-01 | 2026-10-15 |
| Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing | Phase 4 | Active not recruiting | University of Sao Paulo General Hospital | 2005 | 2023-05-23 | 2026-05-04 |
| Effect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained Rowers black chokeberry (Aronia melanocarpa), Placebo - Inflammation;Muscle(S), Oxidative Stress Injury | Phase 4 | Completed | Poznan University of Physical Education | 15 | 2023-04-01 | 2024-04-26 |
| Efficacy and Safety of Pirfenidone in CTD-ILD Pirfenidone, glucocorticoid and immunosuppressant - Pirfenidone, Connective Tissue Diseases | Phase 4 | Unknown | Qilu Hospital of Shandong University | 120 | 2022-06-22 | 2022-11-30 |
| Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis triple therapy, dual-therapy - Dermatomyositis, Adult Type, Interstitial Lung Disease | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 120 | 2022-01-01 | 2022-05-26 |
| Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells Mycophenolate Mofetil - Idiopathic Inflammatory Myopathy, Interstitial Lung Disease | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 20 | 2020-12-01 | 2021-11-22 |
| The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients JAK Inhibitor - Dermatomyositis, Adult Type | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 20 | 2020-04-02 | 2021-07-19 |
| Immunosuppressant Combined With Pirfenidone in CTD-ILD Pirfenidone, DMARDs - Pirfenidone, Connective Tissue Diseases | Phase 4 | Unknown | Qilu Hospital of Shandong University | 200 | 2019-08-16 | 2023-11-18 |
| Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Pirfenidone - Dermatopolymyositis, Interstitial Lung Disease | Phase 4 | Unknown | RenJi Hospital | 57 | 2016-07-01 | 2016-07-01 |
| Abatacept in Juvenile Dermatomyositis Abatacept - Dermatomyositis | Phase 4 | Completed | George Washington University | 10 | 2015-11-01 | 2022-08-29 |
| Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis H.P. Acthar Gel - Dermatomyositis, Juvenile Dermatomyositis | Phase 4 | Completed | The Cleveland Clinic | 19 | 2015-06-15 | 2024-06-11 |
| Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Anti-pandemic H1N1 influenza vaccine - Rheumatoid Arthritis, Spondyloarthritis | Phase 4 | Unknown | University of Sao Paulo | 5000 | 2010-04-01 | 2010-06-28 |
| Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Human papilloma virus vaccine (cervarix) - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus | Phase 4 | Completed | N.M. Wulffraat | 135 | 2009-02-01 | 2017-11-13 |
| Is Myopathy Part of Statin Therapy (IMPOSTER-16) cellulose placebo vs. atorvastatin - Myopathic Conditions | Phase 4 | Withdrawn | Scripps Health | 2005-08-01 | 2022-11-23 |
Dermatomyositis (9) · Lung Diseases, Interstitial (6) · Arthritis, Rheumatoid (5) · Scleroderma, Systemic (5) · Arthritis, Juvenile (4) · Lupus Erythematosus, Systemic (4) · Antiphospholipid Syndrome (2) · Connective Tissue Diseases (2) · Myositis, Inclusion Body (2) · Sjogren's Syndrome (2) · Spondylarthritis (2) · Systemic Vasculitis (2) · Arthritis, Psoriatic (1) · Axial Spondyloarthritis (1)
Musculoskeletal Diseases (18) · Nervous System Diseases (18) · Neuromuscular Diseases (18) · Muscular Diseases (17) · Skin Diseases (13) · Skin and Connective Tissue Diseases (13) · Connective Tissue Diseases (10) · Polymyositis (9) · Respiratory Tract Diseases (8) · Autoimmune Diseases (7) · Immune System Diseases (7) · Lung Diseases (7) · Arthritis (6) · Joint Diseases (6)
pirfenidone (3) · Abatacept (1) · Antirheumatic Agents (1) · Atorvastatin (1) · Dual Anti-Platelet Therapy (1) · Glucocorticoids (1) · Immunosuppressive Agents (1) · Janus Kinase Inhibitors (1) · Maraviroc (1) · Mycophenolic Acid (1) · Oxygen (1) · Papillomavirus Vaccines (1) · Standard of Care (1) · Tacrolimus (1) · Thalidomide (1)
First Affiliated Hospital Xi'an Jiaotong University (2) · Qilu Hospital of Shandong University (2) · University of Sao Paulo General Hospital (2) · Chinese University of Hong Kong (1) · George Washington University (1) · Jay C. Buckey Jr. (1) · N.M. Wulffraat (1) · Poznan University of Physical Education (1) · RenJi Hospital (1) · Rohit Aggarwal, MD (1) · Scripps Health (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The Cleveland Clinic (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University of Sao Paulo (1)
China (7) · United States (4) · Brazil (3) · Hong Kong (1) · Netherlands (1) · Poland (1)
Lan He (2) · Anthony P Fernandez, MD, PhD (1) · Fiona van der KLis, MD, PhD (1) · Guy Berbers, PhD (1) · Harminder Sikand, PharmD (1) · Jay Buckey (1) · Nico M Wulffraat, MD, PhD (1) · Paul S Phillips, MD (1) · Rodolfo V Curiel, MD (1) · Rohit Aggarwal, MD (1) · Shuang Ye, MD (1) · Yang Xiaoyun, Dr. (1)
PMID 16415388, PMID 16899504, PMID 17265499, PMID 17284544, PMID 20843660, PMID 21540203, PMID 21859696, PMID 22089462, PMID 22298793, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23525305, PMID 23723319, PMID 23818263, PMID 24961747, PMID 28968874, PMID 29229575, PMID 30060040, PMID 31314977, PMID 31375890, PMID 31376891, PMID 36657109, PMID 39478532, PMID 40873756, PMID 41679320, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284